News

Pharmabiz9h

Abcentra begins patient dosing in phase 2b FORTIFY trial evaluating orticumab in patients with cardiovascular disease

Abcentra begins patient dosing in phase 2b FORTIFY trial evaluating orticumab in patients with cardiovascular disease: Los Angeles Wednesday, August 13, 2025, 18:00 Hrs [IST] Abce ...
Pharmabiz10h

Record global attendance at CPHI & PMEC China 2025

Our Bureau, Mumbai Wednesday, August 13, 2025, 17:20 Hrs [IST] Sino-international trade is accelerating as CPHI & PMEC China he ...
Pharmabiz10h

Bionova Scientific opens new pDNA facility in Texas to support rapidly growing biopharma industry

Bionova Scientific opens new pDNA facility in Texas to support rapidly growing biopharma industry: Duesseldorf, Germany Wednesday, August 13, 2025, 17:00 Hrs [IST] Bionova Scienti ...
Pharmabiz10h

Artemis Hospitals unveils OPTIC, to transform precision eye care

Artemis Hospitals unveils OPTIC, to transform precision eye care: Our Bureau, Bengaluru Wednesday, August 13, 2025, 16:40 Hrs [IST] Artemis Hospitals unveils the Ocular Profiling ...
Pharmabiz11h

Centrient Pharma joins UN Global Compact, reinforcing its commitment to ethical and sustainable growth

Centrient Pharma joins UN Global Compact, reinforcing its commitment to ethical and sustainable growth: Our Bureau, Bengaluru Wednesday, August 13, 2025, 16:20 Hrs [IST] Centrient ...
Pharmabiz11h

Apriori Bio enters research collaboration with Francis Crick Institute

Apriori Bio, a biotechnology company focused on developing variant-resilient vaccines, announced a research collaboration with the Francis Crick Institute to better understand critical aspects of ...
Pharmabiz11h

Pfizer launches PCV20 for adults in India to offer broad protection against pneumococcal disease

Pfizer launches PCV20 for adults in India to offer broad protection against pneumococcal disease: Our Bureau, Mumbai Wednesday, August 13, 2025, 15:45 Hrs [IST] Pfizer has announc ...
Pharmabiz12h

The 74th IPC’s official information brochure launched, signalling start of event's promotional and outreach activities

The 74th IPC’s official information brochure launched, signalling start of event's promotional and outreach activities: Our Bureau, Bengaluru Wednesday, August 13, 2025, 15:15 H ...
Pharmabiz12h

Biogen and Stoke Therapeutics dose first patient in global phase 3 EMPEROR study of zorevunersen to treat Dravet syndrome

Cambridge, Massachusetts Wednesday, August 13, 2025, 15:00 Hrs [IST] ...
Pharmabiz12h

STEER World with its 200 kg/hr continuous granulation using patented INTEGRAAL system to accelerate pharm manufacturing

STEER World with its 200 kg/hr continuous granulation using patented INTEGRAAL system to accelerate pharm manufacturing: Our Bureau, Bengaluru Wednesday, August 13, 2025, 14:30 Hr ...
Pharmabiz13h

Cohance Lifesciences pumps in Rs. 230 mn to progress on its cGMP oligonucleotide unit at Hyderabad

Cohance Lifesciences pumps in Rs. 230 mn to progress on its cGMP oligonucleotide unit at Hyderabad: Our Bureau, Bengaluru Wednesday, August 13, 2025, 14:15 Hrs [IST] Cohance Lifes ...
Pharmabiz13h

Anixa Biosciences’ chimeric antigen receptor-T cell technology receives US patent

Anixa Biosciences’ chimeric antigen receptor-T cell technology receives US patent: San Jose, California Wednesday, August 13, 2025, 14:00 Hrs [IST] Anixa Biosciences, Inc. (Anix ...